Search

Search Constraints

You searched for: Author/Creator Burns, William

Search Results

2. 812 Urelumab (anti-CD137 agonist) in combination with vaccine and nivolumab treatments is safe and associated with pathologic response as neoadjuvant and adjuvant therapy for resectable pancreatic cancer. (9th November 2020)

6. High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy. (10th February 2022)

7. Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas. Issue 2 (18th August 2022)

9. Should non-invasive diffuse main-duct intraductal papillary mucinous neoplasms be treated with total pancreatectomy?. Issue 5 (May 2022)

10. Syndromic neurodevelopmental disorder associated with de novo variants in DDX23. Issue 10 (29th May 2021)